120 related articles for article (PubMed ID: 29180109)
1. Relaxin induces up-regulation of ADAM10 metalloprotease in RXFP1-expressing cells by PI3K/AKT signaling.
Boccalini G; Sassoli C; Bani D; Nistri S
Mol Cell Endocrinol; 2018 Sep; 472():80-86. PubMed ID: 29180109
[TBL] [Abstract][Full Text] [Related]
2. Relaxin prevents cardiac fibroblast-myofibroblast transition via notch-1-mediated inhibition of TGF-β/Smad3 signaling.
Sassoli C; Chellini F; Pini A; Tani A; Nistri S; Nosi D; Zecchi-Orlandini S; Bani D; Formigli L
PLoS One; 2013; 8(5):e63896. PubMed ID: 23704950
[TBL] [Abstract][Full Text] [Related]
3. Intracellular signaling pathways involved in the relaxin-induced proliferation of rat Sertoli cells.
Nascimento AR; Pimenta MT; Lucas TF; Royer C; Porto CS; Lazari MF
Eur J Pharmacol; 2012 Sep; 691(1-3):283-91. PubMed ID: 22819701
[TBL] [Abstract][Full Text] [Related]
4. Relaxin attenuates aristolochic acid induced human tubular epithelial cell apoptosis in vitro by activation of the PI3K/Akt signaling pathway.
Xie XC; Zhao N; Xu QH; Yang X; Xia WK; Chen Q; Wang M; Fei X
Apoptosis; 2017 Jun; 22(6):769-776. PubMed ID: 28386751
[TBL] [Abstract][Full Text] [Related]
5. Relaxin in paraventricular nucleus contributes to sympathetic overdrive and hypertension via PI3K-Akt pathway.
Sun HJ; Chen D; Han Y; Zhou YB; Wang JJ; Chen Q; Li YH; Gao XY; Kang YM; Zhu GQ
Neuropharmacology; 2016 Apr; 103():247-56. PubMed ID: 26746861
[TBL] [Abstract][Full Text] [Related]
6. The anti-fibrotic actions of relaxin are mediated through AT
Wang C; Pinar AA; Widdop RE; Hossain MA; Bathgate RAD; Denton KM; Kemp-Harper BK; Samuel CS
FASEB J; 2020 Jun; 34(6):8217-8233. PubMed ID: 32297670
[TBL] [Abstract][Full Text] [Related]
7. Rh-relaxin-2 attenuates degranulation of mast cells by inhibiting NF-κB through PI3K-AKT/TNFAIP3 pathway in an experimental germinal matrix hemorrhage rat model.
Li P; Zhao G; Chen F; Ding Y; Wang T; Liu S; Lu W; Xu W; Flores J; Ocak U; Zhang T; Zhang JH; Tang J
J Neuroinflammation; 2020 Aug; 17(1):250. PubMed ID: 32859236
[TBL] [Abstract][Full Text] [Related]
8. [Protective effect of glucagon-like peptide-1 analogue on cardiomyocytes injury induced by hypoxia/reoxygenation].
Liu MM; Shen YF; Chen C; Lai XY; Zhang MY; Yu R
Zhonghua Nei Ke Za Zhi; 2016 Apr; 55(4):311-6. PubMed ID: 27030622
[TBL] [Abstract][Full Text] [Related]
9. The actions of relaxin family peptides on signal transduction pathways activated by the relaxin family peptide receptor RXFP4.
Ang SY; Hutchinson DS; Evans BA; Hossain MA; Patil N; Bathgate RA; Kocan M; Summers RJ
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):105-111. PubMed ID: 27888281
[TBL] [Abstract][Full Text] [Related]
10. Relaxin Attenuates Contrast-Induced Human Proximal Tubular Epithelial Cell Apoptosis by Activation of the PI3K/Akt Signaling Pathway In Vitro.
Xie XC; Cao Y; Yang X; Xu QH; Wei W; Wang M
Biomed Res Int; 2017; 2017():2869405. PubMed ID: 28540295
[No Abstract] [Full Text] [Related]
11. Relaxin inhibits renal myofibroblast differentiation via RXFP1, the nitric oxide pathway, and Smad2.
Mookerjee I; Hewitson TD; Halls ML; Summers RJ; Mathai ML; Bathgate RA; Tregear GW; Samuel CS
FASEB J; 2009 Apr; 23(4):1219-29. PubMed ID: 19073841
[TBL] [Abstract][Full Text] [Related]
12. Relaxin activates AMPK-AKT signaling and increases glucose uptake by cultured cardiomyocytes.
Aragón-Herrera A; Feijóo-Bandín S; Rodríguez-Penas D; Roselló-Lletí E; Portolés M; Rivera M; Bigazzi M; Bani D; Gualillo O; González-Juanatey JR; Lago F
Endocrine; 2018 Apr; 60(1):103-111. PubMed ID: 29411306
[TBL] [Abstract][Full Text] [Related]
13. Relaxin protects cardiac muscle cells from hypoxia/reoxygenation injury: involvement of the Notch-1 pathway.
Boccalini G; Sassoli C; Formigli L; Bani D; Nistri S
FASEB J; 2015 Jan; 29(1):239-49. PubMed ID: 25342127
[TBL] [Abstract][Full Text] [Related]
14. Relaxin induces matrix-metalloproteinases-9 and -13 via RXFP1: induction of MMP-9 involves the PI3K, ERK, Akt and PKC-ζ pathways.
Ahmad N; Wang W; Nair R; Kapila S
Mol Cell Endocrinol; 2012 Nov; 363(1-2):46-61. PubMed ID: 22835547
[TBL] [Abstract][Full Text] [Related]
15. Relaxin (RLX) and estrogen affect estrogen receptor alpha, vascular endothelial growth factor, and RLX receptor expression in the neonatal porcine uterus and cervix.
Yan W; Chen J; Wiley AA; Crean-Harris BD; Bartol FF; Bagnell CA
Reproduction; 2008 May; 135(5):705-12. PubMed ID: 18304981
[TBL] [Abstract][Full Text] [Related]
16. H3 relaxin demonstrates antifibrotic properties via the RXFP1 receptor.
Hossain MA; Man BC; Zhao C; Xu Q; Du XJ; Wade JD; Samuel CS
Biochemistry; 2011 Mar; 50(8):1368-75. PubMed ID: 21229994
[TBL] [Abstract][Full Text] [Related]
17. Triazine herbicides inhibit relaxin signaling and disrupt nitric oxide homeostasis.
Park SE; Lim SR; Choi HK; Bae J
Toxicol Appl Pharmacol; 2016 Sep; 307():10-18. PubMed ID: 27431321
[TBL] [Abstract][Full Text] [Related]
18. 25-Hydroxyl-protopanaxatriol protects against H
Wang Z; Su G; Zhang Z; Dong H; Wang Y; Zhao H; Zhao Y; Sun Q
Biomed Pharmacother; 2018 Mar; 99():33-42. PubMed ID: 29324310
[TBL] [Abstract][Full Text] [Related]
19. Protective role of relaxin in a mouse model of aristolochic acid nephropathy.
Yang X; Thorngren D; Chen Q; Wang M; Xie X
Biomed Pharmacother; 2019 Jul; 115():108917. PubMed ID: 31060002
[TBL] [Abstract][Full Text] [Related]
20. A single adenovirus-mediated relaxin delivery attenuates established liver fibrosis in rats.
Kim JK; Lee JI; Paik YH; Yun CO; Chang HY; Lee SY; Lee KS
J Gene Med; 2016; 18(1-3):16-26. PubMed ID: 26769058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
